硬化性苔藓相关尿道狭窄保守治疗的长期结局
回顾性分析111例接受内镜干预和/或CIC联合尿道内类固醇保守治疗的硬化性苔藓相关尿道狭窄患者,中位随访68.5个月。29例(26.1%)保守治疗失败,中位失败时间61个月;后尿道受累及闭塞性狭窄特征者失败更常见。多数患者前两年反应良好,但长期监测仍属必要。
要点
- 26.1%患者保守治疗失败,中位失败时间61个月。
- 后尿道受累和闭塞性狭窄特征与失败风险升高相关。
- 最常见失败原因为持续困扰的下尿路症状(34%)。
核心结论
- 多数患者前两年对保守治疗反应良好,但随时间推移失败风险逐渐增加,需长期监测。
研究设计与样本
- 回顾性病历复习,纳入2005至2024年接受内镜干预和/或CIC联合尿道内类固醇保守治疗的LS-USD患者111例,中位随访68.5个月(范围1–237个月)。
主要发现
- 29例(26.1%)保守治疗失败,2年内失败率8.5%,5年内13.6%。
- 中位失败时间61个月;1年时24%失败,5年时55%失败,最晚失败发生在17年。
- 后尿道受累和闭塞性狭窄特征的患者失败更常见。
- 失败原因包括持续困扰的下尿路症状(34%)、急性尿潴留(24%)、合并隐匿阴茎修复(10%)和反复尿路感染(10%)。
关键数值与推荐
- 保守治疗失败定义为需要重建手术或长期留置导尿管。
临床怎么用
- 对LS-USD患者可先行保守治疗,但应告知长期失败风险并安排长期随访。
- 后尿道受累或闭塞性狭窄特征者可能需更密切监测或早期考虑重建手术。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the long-term outcomes of conservative management of lichen sclerosus-induced urethral stricture disease (LS-USD). METHODS: We retrospectively reviewed charts of patients with LS-USD treated conservatively with endoscopic intervention (eg, dilation, urethrotomy) and/or CIC +/- intraurethral steroids, between 2005 and 2024. Failure of conservative management (CM) was defined as the need for reconstructive surgery or chronic catheter. Patient demographics, medical history, and objective stricture data were collected. Statistical analysis included Kruskal-Wallis, ANOVA, chi-square, Fisher's exact test, and Kaplan-Meier survival curves. RESULTS: 111 patients started CM for LS-USD with a median follow-up of 68.5 months (range 1-237 months). 29 (26.1%) patients failed treatment-8.5% within 2 years and 13.6% within 5 years. The median time to failure was 61 months, with 24% failing by 1 year, 55% by 5 years, and the latest failure at 17 years. Failure was more common in patients with posterior urethral involvement and obliterative stricture features. The most common reasons for failure of CM included persistent bothersome lower urinary tract symptoms (34%), development of acute urinary retention (24%), concomitant buried penis repair (10%), and recurrent urinary tract infections (10%). CONCLUSION: Although the majority of patients respond well to CM within the first two years, long-term monitoring is essential due to the progressive risk of treatment failure over time.
引用
- Saltman AJ, Callegari M, Rizvi TZ, et al. Long-term Outcomes of Conservative Management for Lichen Sclerosus Urethral Stricture Disease to ensure consistency. Urology. 2025. PMID: 40368218. doi:10.1016/j.urology.2025.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。